share_log

深交所向深圳市航运健康科技发出监管函,其减持派林生物(000403.SZ)股份未按规定停止交易

Shenzhen Stock Exchange issued a supervision letter to Shenzhen Shipping Health Technology, and its reduced stake in 000403.SZ failed to stop trading in accordance with the regulations.

智通財經 ·  Dec 20, 2021 09:20

Zhitong Financial APP learned that on December 20, the Shenzhen Stock Exchange issued a supervision letter to Shenzhen Shipping Health Technology Co., Ltd. On December 11, 2021, the company disclosed the simplified equity change report through Paishuanglin Biopharmaceutical Co., Ltd. (000403.SZ). From June 18, 2021 to December 8, 2021, the proportion of shares held by the company in listed companies decreased from 13.37% to 8.013%, with a cumulative change of 5.36%. When the cumulative reduction reaches 5%, the company fails to stop trading in accordance with the provisions of paragraph 2 of Article 13 of the measures for the Administration of acquisitions of listed companies (revised in 2020). The above actions violate the relevant regulations of the Shenzhen Stock Exchange.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment